It’s been all change in the European Union this month, most of it a result of the Lisbon Treaty: a new president of the European Council, a new position of high representative for foreign affairs and security, and now a new-look European Commission with a range of novel portfolios...
Scrip Regulatory Affairs
EU pharma changes bring new responsibilities - and some confusion
30 November 2009
Ian Schofield
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Commission strips drug safety measures from EU patient info proposal to meet July 2012 deadline
- French govt promises "culture shock" in drug regulation, while price cuts and levies loom
- French bill tightens up on safety and conflicts of interest, but not drug approval criteria
- US to fortify "Common Rule" to improve study participant safety, oversight
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
